Abacus Life [ABL] vs MetLife [MET] Detailed Stock Comparison

Abacus Life Inc.

NASDAQ
Loading...

MetLife Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Abacus Life Inc. wins in 7 metrics, MetLife Inc. wins in 13 metrics, with 0 ties. MetLife Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Abacus Life Inc. MetLife Inc. Better
P/E Ratio (TTM) 169.40 16.15 MetLife Inc.
Price-to-Book Ratio 1.90 1.76 MetLife Inc.
Debt-to-Equity Ratio 94.29 225.97 Abacus Life Inc.
PEG Ratio -0.85 -0.48 MetLife Inc.
EV/EBITDA 15.86 15.07 MetLife Inc.
Profit Margin (TTM) 5.62% 4.38% Abacus Life Inc.
Operating Margin (TTM) 35.59% 4.67% Abacus Life Inc.
EBITDA Margin (TTM) 35.59% 4.67% Abacus Life Inc.
Return on Equity 3.18% 12.02% MetLife Inc.
Return on Assets (TTM) 4.93% 0.46% Abacus Life Inc.
Free Cash Flow (TTM) $-209.62M $17.09B MetLife Inc.
Dividend Yield 3.02% 3.03% MetLife Inc.
1-Year Return 16.17% 14.85% Abacus Life Inc.
Price-to-Sales Ratio (TTM) 4.21 0.64 MetLife Inc.
Enterprise Value $1.14B $89.84B MetLife Inc.
EV/Revenue Ratio 5.82 1.17 MetLife Inc.
Gross Profit Margin (TTM) 87.84% N/A N/A
Revenue per Share (TTM) $2 $115 MetLife Inc.
Earnings per Share (Diluted) $0.05 $4.71 MetLife Inc.
Beta (Stock Volatility) -0.07 0.73 Abacus Life Inc.
Short % of Float 49.18% 2.61% MetLife Inc.

Abacus Life Inc. vs MetLife Inc. Stock Performance Analysis

Loading Price Chart...

ABL
MET

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Abacus Life Inc.-2.71%-10.94%-9.68%-13.90%20.99%4.80%
MetLife Inc.-1.33%3.89%9.88%26.75%6.11%9.14%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Abacus Life Inc.16.17%-12.73%-8.37%-7.99%-7.99%-7.99%
MetLife Inc.14.85%60.07%52.38%136.40%146.91%99.01%

Performance & Financial Health Analysis: Abacus Life Inc. vs MetLife Inc.

MetricABLMET
Market Information
Market Cap i$971.66M$49.60B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i495,8493,185,584
90 Day Avg. Volume i483,8223,535,355
Last Close$8.98$87.66
52 Week Range$4.60 - $10.53$67.33 - $89.62
% from 52W High-14.76%-2.19%
All-Time High$13.25 (Feb 05, 2024)$89.62 (Jun 15, 2026)
% from All-Time High-32.23%-2.19%
Growth Metrics
Quarterly Revenue Growth1.24%0.28%
Quarterly Earnings Growth1.24%-0.36%
Financial Health
Profit Margin (TTM) i0.06%0.04%
Operating Margin (TTM) i0.36%0.05%
Return on Equity (TTM) i0.03%0.12%
Debt to Equity (MRQ) i94.29225.97
Cash & Liquidity
Book Value per Share (MRQ)$4.45$43.33
Cash per Share (MRQ)$0.88$39.31
Operating Cash Flow (TTM) i$-110,223,816$17.09B
Levered Free Cash Flow (TTM) i$41.56M$-12,738,499,584
Dividends
Last 12-Month Dividend Yield i3.02%3.03%
Last 12-Month Dividend i$0.20$2.28

Valuation & Enterprise Metrics Analysis: Abacus Life Inc. vs MetLife Inc.

MetricABL (Mar 05, 2026)MET (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i169.4016.15
Forward P/E i8.566.95
PEG Ratio i-0.85-0.48
Price to Sales (TTM) i4.210.64
Price to Book (MRQ) i1.901.76
Market Capitalization
Market Capitalization i$971.66M$49.60B
Enterprise Value i$1.14B$89.84B
Enterprise Value Metrics
Enterprise to Revenue i5.821.17
Enterprise to EBITDA i15.8615.07
Risk & Other Metrics
Beta i-0.070.73
Book Value per Share (MRQ) i$4.45$43.33

Financial Statements Comparison: Abacus Life Inc. vs MetLife Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricABL (2024)MET (2025)
Revenue/Sales i111.92M75.65B
Cost of Goods Sold i11.37MN/A
COGS % of Revenue i10.2%0.0%
Gross Profit i100.55MN/A
Gross Margin i89.8%0.0%
Research & Development iN/AN/A
Operating Income (EBIT) i1.84MN/A
Operating Margin i1.6%0.0%
EBITDA i12.19MN/A
EBITDA Margin i10.9%0.0%
Pre-Tax Income i-19.43M4.66B
Pre-Tax Income % of Revenue i-17.4%6.2%
Income Tax i5.48M1.26B
Income Tax % of Revenue i4.9%1.7%
Net Income (Profit) i-24.92M3.40B
Profit Margin i-22.3%4.5%

Balance Sheet & Liquidity Metrics

MetricABL (2024)MET (2025)
Cash & Equivalents i131.94M22.03B
Total Current Assets i159.56MN/A
Total Current Assets % of Revenue i142.6%0.0%
Total Current Liabilities i62.47MN/A
Total Current Liabilities % of Revenue i55.8%0.0%
Long-Term Debt i346.97M18.62B
Long-Term Debt % of Revenue i310.0%24.6%
Total Shareholders Equity i423.29M28.92B
Retained Earnings i-57.90M44.29B
Retained Earnings % of Revenue i-51.7%58.5%
Property, Plant & Equipment i4.72MN/A

Cash Flow Statement Comparison

MetricABL (2024)MET (2025)
Operating Cash Flow i-213.60M-873.00M
Operating Cash Flow % of Revenue i-190.8%-1.2%
Capital Expenditures i-786,236N/A
Free Cash Flow i-209.62M17.09B
FCF Margin i-187.3%22.6%
Debt Repayment i-32.23M-2.62B
Common Stock Repurchase i-10.74M-3.88B

Short Interest & Institutional Ownership Analysis

MetricABLMET
Shares Short i6.48M14.12M
Short Ratio i8.953.48
Short % of Float i49.18%2.61%
Shares Outstanding i97.70M655.33M
Float Shares i32.63M544.55M
% Held by Insiders i61.69%16.44%
% Held by Institutions i30.86%76.90%
% Held by Public i7.45%6.66%

Dividend Analysis & Yield Comparison: Abacus Life Inc. vs MetLife Inc.

MetricABLMET
Last 12-Month Dividend i$0.20$2.28
Last 12-Month Dividend Yield i3.02%3.03%
3-Year Avg Annual Dividend i$0.07$2.19
3-Year Avg Dividend Yield i3.02%0.78%
3-Year Total Dividends i$0.20$6.56
Ex-Dividend DateDec 02, 2025Feb 03, 2026